Anelleo, Inc. is located in Chapel Hill, North Carolina. Current support and funding is provided by NIH-NICHD (Phase I STTR) and strategic partners (Carbon, Inc. & undisclosed pharma partnerships) to allow AnelleO to complete prototyping, preclinical studies, and IND-enabling studies.
AnelleO is harnessing the advancements in the speed and scale of 3D printing technology for novel solutions in Women’s Health. AnelleO’s first products are Intravaginal Rings (IVRs), which offer a unique platform for sustained delivery of therapeutics – a non-invasive, self-administered and retrievable platform that can deliver drugs over a period of weeks or months.
Contact us at: [email protected]
Legal Information:
Conflict of Interest Policy
